The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII.
D000510:Alpha-Globulins / Q000032:analysis; D001609:Beta-Globulins / Q000032:analysis; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001797:Blood Protein Electrophoresis; D002848:Chromatography, DEAE-Cellulose; D004553:Electric Conductivity; D005164:Factor IX / Q000302:isolation & purification; D005167:Factor VII / Q000302:isolation & purification; D005170:Factor X / Q000302:isolation & purification; D002836:Hemophilia B / Q000628:therapy; D006801:Humans; D008722:Methods; D011516:Prothrombin / Q000302:isolation & purification; D012709:Serum Albumin / Q000032:analysis; D013053:Spectrophotometry; D005719:gamma-Globulins / Q000032:analysis
D000510:Alpha-Globulins; D001609:Beta-Globulins; D001779:Blood Coagulation Factors; D012709:Serum Albumin; D005719:gamma-Globulins; D005167:Factor VII; D011516:Prothrombin; D005164:Factor IX; D005170:Factor X